New perspectives on glutamate receptor antagonists as antidepressants

被引：0
作者：
ChiHye Chung
机构：
[1] Konkuk University,Department of Biological Sciences
来源：
Archives of Pharmacal Research | 2012年 / 35卷
关键词：
NMDA; Ketamine; Major Depressive Disorder; Glutamate Receptor Antagonist; NMDAR Antagonist;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Classical antidepressants elevate the monoamine levels in the brain by preventing re-uptake of monoamines after release. Treatment of depression with monoamine re-uptake inhibitors is associated with low clinical efficacy and remission rate due to the delayed onset of therapeutic responses. Therefore, the development of alternative antidepressants is essential for successful treatment of this disease. Recently, glutamate receptor antagonists including ketamine and 2-methyl-6-(phenylethynyl)-pyridine (MPEP) have received wide attention as fast-acting therapeutic alternatives for treatment of depression.
引用
收藏
页码：573 / 577
页数：4
相关论文
共 50 条
  • [41] Prospects of glutamate antagonists in the therapy of Parkinson's disease
    Blandini, F
    Greenamyre, JT
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1998, 12 (01) : 4 - 12
  • [42] Glutamate receptor antagonists and growth factors modulate dentate granule cell neurogenesis in organotypic, rat hippocampal slice cultures
    Poulsen, FR
    Blaabjerg, M
    Montero, M
    Zimmer, J
    BRAIN RESEARCH, 2005, 1051 (1-2) : 35 - 49
  • [43] Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists
    Koike, Hiroyuki
    Iijima, Michihiko
    Chaki, Shigeyuki
    NEUROPHARMACOLOGY, 2011, 61 (08) : 1419 - 1423
  • [44] Effect of glutamate receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats
    Kawasaki, Y
    Jin, CY
    Suemaru, K
    Kawasaki, H
    Shibata, K
    Choshi, T
    Hibino, S
    Gomita, Y
    Araki, H
    BRITISH JOURNAL OF PHARMACOLOGY, 2005, 145 (06) : 751 - 757
  • [45] The development of glutamate-based antidepressants is taking longer than expected
    Garay, Ricardo
    Zarate, Carlos A.
    Cavero, Icilio
    Kim, Yong-Ku
    Charpeaud, Thomas
    Skolnick, Phil
    DRUG DISCOVERY TODAY, 2018, 23 (10) : 1689 - 1692
  • [46] Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants
    Chaki, Shigeyuki
    Fukumoto, Kenichi
    PHARMACEUTICALS, 2015, 8 (03): : 590 - 606
  • [47] NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test
    Ghasemi, M.
    Raza, M.
    Dehpour, A. R.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (04) : 585 - 594
  • [48] Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism
    Pilc, Andrzej
    Machaczka, Agata
    Kawalec, Pawel
    Smith, Jodi L.
    Witkin, Jeffrey M.
    EXPERT OPINION ON DRUG DISCOVERY, 2022, 17 (10) : 1131 - 1146
  • [49] K2P channels and NMDA receptor as new targets of fast onset antidepressants
    LI Yang
    GUO Fei
    MA Yu-qin
    中国药理学与毒理学杂志, 2018, 32 (09) : 711 - 711
  • [50] ANTAGONISTS OF THE NMDA RECEPTOR-CHANNEL COMPLEX AND MOTOR COORDINATION
    CARTER, AJ
    LIFE SCIENCES, 1995, 57 (10) : 917 - 929
12345